SEC Comment Letter 0000000000-25-002009 to ENvue Medical, Inc. (FEED)
ENvue Medical, Inc.
Date: Feb. 20, 2025 · CIK: 0001326706 · Accession: 0000000000-25-002009
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284973
Letter
February 20, 2025 Brian Murphy Chief Executive Officer NanoVibronix, Inc. 969 Pruitt Place Tyler, TX 75703 Re:NanoVibronix, Inc. Registration Statement on Form S-1 Filed February 14, 2025 File No. 333-284973 Dear Brian Murphy: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Alla Digilova, Esq.
Show Raw Text
February 20, 2025
Brian Murphy
Chief Executive Officer
NanoVibronix, Inc.
969 Pruitt Place
Tyler, TX 75703
Re:NanoVibronix, Inc.
Registration Statement on Form S-1
Filed February 14, 2025
File No. 333-284973
Dear Brian Murphy:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Alla Digilova, Esq.